Activated H-Ras regulates hematopoietic cell survival by modulating Survivin

Biochemical and Biophysical Research Communications
Seiji Fukuda, Louis M Pelus

Abstract

Survivin expression and Ras activation are regulated by hematopoietic growth factors. We investigated whether activated Ras could circumvent growth factor-regulated Survivin expression and if a Ras/Survivin axis mediates growth factor independent survival and proliferation in hematopoietic cells. Survivin expression is up-regulated by IL-3 in Ba/F3 and CD34+ cells and inhibited by the Ras inhibitor, farnesylthiosalicylic acid. Over-expression of constitutively activated H-Ras (CA-Ras) in Ba/F3 cells blocked down-modulation of Survivin expression, G0/G1 arrest, and apoptosis induced by IL-3 withdrawal, while dominant-negative (DN) H-Ras down-regulated Survivin. Survivin disruption by DN T34A Survivin blocked CA-Ras-induced IL-3-independent cell survival and proliferation; however, it did not affect CA-Ras-mediated enhancement of S-phase, indicating that the anti-apoptotic activity of CA-Ras is Survivin dependent while its S-phase enhancing effect is not. These results indicate that CA-Ras modulates Survivin expression independent of hematopoietic growth factors and that a CA-Ras/Survivin axis regulates survival and proliferation of transformed hematopoietic cells.

References

Mar 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·V DuronioJ W Schrader
Nov 17, 1995·The Journal of Biological Chemistry·K TeradaT Satoh
Nov 26, 1999·Proceedings of the National Academy of Sciences of the United States of America·B JansenK Wolff
Mar 29, 2000·The Journal of Biological Chemistry·A PapapetropoulosW C Sessa
Nov 9, 2000·Proceedings of the National Academy of Sciences of the United States of America·D S O'ConnorD C Altieri
Nov 25, 2000·Cellular and Molecular Life Sciences : CMLS·P Crespo, J León
May 29, 2002·Oncogene·Jiang Zhu, Stephen G Emerson
Dec 14, 2002·Blood·Mustafa BenekliMeir Wetzler
Jan 2, 2003·Nature Reviews. Cancer·Dario C Altieri
Sep 14, 2004·Oncogene·Zhanxiang WangLouis M Pelus

❮ Previous
Next ❯

Citations

Mar 15, 2006·European Journal of Haematology·Rosangela InvernizziEdoardo Ascari
Aug 23, 2008·The Tohoku Journal of Experimental Medicine·Tetsuharu ShinjyoNobuyuki Takasu
Feb 4, 2011·OncoTargets and Therapy·Jonathan R Aspe, Nathan R Wall
Oct 2, 2007·FEBS Letters·Klaus W SommerChrista Cerni
Nov 21, 2015·Molecular Cancer·C SanhuezaA F G Quest
Jan 18, 2013·Cell Cycle·Awet Tecleab, Saïd M Sebti
Aug 27, 2005·Arteriosclerosis, Thrombosis, and Vascular Biology·Grace J WangMichael S Conte
Jul 20, 2005·Oncogene·Akifumi KandaMasaaki Tatsuka
Nov 3, 2011·Molecular and Cellular Biochemistry·Chandrabose Sureka, Thiyagarajan Ramesh
Mar 29, 2018·International Journal of Molecular Sciences·Andrea SantarelliLorenzo Lo Muzio
Jul 22, 2020·Stem Cell Reviews and Reports·Neerada Meenakshi WarrierPraveen Kumar
Jan 24, 2007·Molecular Cancer Therapeutics·Aparna V SarthyStephen W Fesik

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis